31.1. Analysis.
Comparison 31 NRD‐101 (Suvenyl) versus placebo (saline plus oral placebo), Outcome 1 Pain (0‐100 mm VAS) change between baseline and 45 to 52 weeks post‐injection.
Comparison 31 NRD‐101 (Suvenyl) versus placebo (saline plus oral placebo), Outcome 1 Pain (0‐100 mm VAS) change between baseline and 45 to 52 weeks post‐injection.